The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
Open accessAbstract
Angiopoietin-2 (ANG-2) is a key regulator of angiogenesis that exerts context-dependent effects on ECs. ANG-2 binds the endothelial-specific receptor tyrosine kinase 2 (TIE2) and acts as a negative regulator of ANG-1/TIE2 signaling during angiogenesis, thereby controlling the responsiveness of ECs to exogenous cytokines. Recent data from tumors indicate that under certain conditions ANG-2 can also promote angiogenesis. However, the molecular mechanisms of dual ANG-2 functions are poorly understood. Here, we identify a model for the opposing roles of ANG-2 in angiogenesis. We found that angiogenesis-activated endothelium harbored a subpopulation of TIE2-negative ECs (TIE2lo). TIE2 expression was downregulated in angiogenic ECs, which abundantly expressed several integrins. ANG-2 bound to these integrins in TIE2lo ECs, subsequently inducing, in a TIE2-independent manner, phosphorylation of the integrin adaptor protein FAK, resulting in RAC1 activation, migration, and sprouting angiogenesis. Correspondingly, in vivo ANG-2 blockade interfered with integrin signaling and inhibited FAK phosphorylation and sprouting angiogenesis of TIE2lo ECs. These data establish a contextual model whereby differential TIE2 and integrin expression, binding, and activation control the role of ANG-2 in angiogenesis. The results of this study have immediate translational implications for the therapeutic exploitation of angiopoietin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent studies have demonstrated that beyond the primary signaling mode through TIE2, ANGPTs can also signal via integrins to modulate vascular responses (13, 21–25).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Integrins, which regulate endothelial cell–cell and cell–matrix interactions, have been identified as alternative receptors for the angiopoietins in certain Tie2-negative non-endothelial cells22232425, and in the endothelial tip cells of angiogenic vessel sprouts, which express low levels of Tie2 (refs 26, 27).”
From Endothelial destabilization by angiopoietin-2 via integrin β1 activation (2015) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Our results differentiating between Ang1- and Ang2-mediated β1-integrin activation in the absence of Tie2 are in line with Ang2-integrin signalling in the endothelial tip cells, which express high Ang2 but low Tie2 levels27.”
From Endothelial destabilization by angiopoietin-2 via integrin β1 activation (2015) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,815
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S. H., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,872
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg‐Buchholz, K., Fujiwara, Y., Gendron‐Maguire, M., Gridley, T., Wolburg, H., Risau, W., & Qin, Y. (1995) · Nature · doi:10.1038/376070a0 · Cited by 1,821
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Koh, G. Y., Thurston, G., & Alitalo, K. K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,512
Self-citationGale, N. W., Thurston, G., Hackett, S. F., Renard, R. A., Wang, Q., McClain, J., Martin, C., Witte, C. L., Witte, M. H., Jackson, D. G., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00217-4 · Cited by 1,017
Random versus directionally persistent cell migration
Petrie, R. J., Doyle, A. D., & Yamada, K. M. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2729 · Cited by 995
Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., & Breitman, M. L. (1994) · Genes & Development · doi:10.1101/gad.8.16.1897 · Cited by 985
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Self-citationMazzieri, R., Pucci, F., Moi, D., Zonari, E., Ranghetti, A., Berti, A., Politi, L. S., Gentner, B., Brown, J. L., Naldini, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.005 · Cited by 639
Cited by
Sorted by citations
Pericytes of the neurovascular unit: key functions and signaling pathways
Sweeney, M. D., Ayyadurai, S., & Zlokovic, B. V. (2016) · Nature Neuroscience · doi:10.1038/nn.4288 · Cited by 1,125
Therapeutic strategies for enhancing angiogenesis in wound healing
Veith, A. P., Henderson, K., Spencer, A., Sligar, A. D., & Baker, A. B. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.010 · Cited by 1,047
Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology
Augustin, H. G., & Koh, G. Y. (2017) · Science · doi:10.1126/science.aal2379 · Cited by 790
Self-citationMechanisms of macular edema: Beyond the surface
Daruich, A., Matet, A., Moulin, A., Kowalczuk, L., Nicolas, M., Sellam, A., Rothschild, P.-R., Omri, S., Gélizé, E., Jonet, L., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.006 · Cited by 744
Nanocomposite scaffolds for accelerating chronic wound healing by enhancing angiogenesis
Nosrati, H., Khouy, R. A., Nosrati, A., Khodaei, M., Banitalebi-Dehkordi, M., Ashrafi-Dehkordi, K., Sanami, S., & Alizadeh, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00755-7 · Cited by 729
Fagiani, E., & Christofori, G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.018 · Cited by 702
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
Welti, J. C., Loges, S., Dimmeler, S., & Carmeliet, P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70212 · Cited by 601
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology
Akwii, R. G., Sajib, M. S., Zahra, F. T., & Mikelis, C. M. (2019) · Cells · doi:10.3390/cells8050471 · Cited by 566
YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation
Kim, J., Kim, Y. H., Kim, J., Park, D. Y., Bae, H., Lee, D. H., Kim, K. H., Hong, S. P., Jang, S. P., Kubota, Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93825 · Cited by 406
Retinal vasculature development in health and disease
Selvam, S., Kumar, T., & Fruttiger, M. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.001 · Cited by 363
Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis
Corliss, B. A., Azimi, M. S., Munson, J. M., Peirce, S. M., & Murfee, W. L. (2016) · Microcirculation · doi:10.1111/micc.12259 · Cited by 356
Pericyte-expressed Tie2 controls angiogenesis and vessel maturation
Teichert, M., Milde, L., Holm, A., Stanicek, L., Gengenbacher, N., Savant, S., Ruckdeschel, T., Hasanov, Z., Srivastava, K., Hu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms16106 · Cited by 359
Self-citationBeyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 357
Plastic roles of pericytes in the blood–retinal barrier
Park, D. Y., Lee, J., Kim, J., Kim, K., Hong, S., Han, S., Kubota, Y., Augustin, H. G., Ding, L., Kim, J. W., et al. (2017) · Nature Communications · doi:10.1038/ncomms15296 · Cited by 336
Self-citationMechanisms of Vessel Pruning and Regression
Korn, C., & Augustin, H. G. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.06.004 · Cited by 325
Self-citationJoussen, A. M., Ricci, F., Paris, L. P., Korn, C., Quezada-Ruiz, C., & Zarbin, M. A. (2021) · Eye · doi:10.1038/s41433-020-01377-x · Cited by 308
Endothelial destabilization by angiopoietin-2 via integrin β1 activation
Hakanpaa, L., Sipila, T., Leppanen, V.-M., Gautam, P., Nurmi, H., Jacquemet, G., Eklund, L., Ivaska, J., Alitalo, K., & Saharinen, P. (2015) · Nature Communications · doi:10.1038/ncomms6962 · Cited by 287
Tie1 controls angiopoietin function in vascular remodeling and inflammation
Korhonen, E. A., Lampinen, A., Giri, H., Anisimov, A., Kim, M., Allen, B., Fang, S., D’Amico, G., Sipilä, T. J., Lohela, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84923 · Cited by 283
Passing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation
Wettschureck, N., Strilić, B., & Offermanns, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00037.2018 · Cited by 290
Macrophages regulate corpus luteum development during embryo implantation in mice
Care, A. S., Diener, K. R., Jasper, M. J., Brown, H. M., Ingman, W. V., & Robertson, S. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60561 · Cited by 261
Cell–matrix signals specify bone endothelial cells during developmental osteogenesis
Langen, U. H., Pitulescu, M. E., Kim, J. M., Enriquez-Gasca, R., Sivaraj, K. K., Kusumbe, A. P., Singh, A., Russo, J. D., Bixel, M. G., Zhou, B., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3476 · Cited by 259
Role of Angiopoietin-2 in Adaptive Tumor Resistance to VEGF Signaling Blockade
Rigamonti, N., Kadioglu, E., Keklikoglou, I., Wyser Rmili, C., Leow, C. C., & De Palma, M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.059 · Cited by 247
Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2
Choi, H.-J., Zhang, H., Park, H., Choi, K.-S., Lee, H., Agrawal, V., Kim, Y., & Kwon, Y. (2015) · Nature Communications · doi:10.1038/ncomms7943 · Cited by 252
Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation
Kim, M., Allen, B. M., Korhonen, E. A., Nitschké, M., Yang, H. W., Bałuk, P., Saharinen, P., Alitalo, K. K., Daly, C., Thurston, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84871 · Cited by 248
Angiopoietin signaling in the vasculature
Eklund, L., & Saharinen, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.011 · Cited by 253
Daly, C., Eichten, A., Castanaro, C., Pasnikowski, E. M., Adler, A. P., Lalani, A. S., Papadopoulos, N. J., Kyle, A. H., Minchinton, A. I., Yancopoulos, G. D., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2064 · Cited by 230
Mechanical stimulation of mesenchymal stem cells: Implications for cartilage tissue engineering
Fahy, N., Alini, M., & Stoddart, M. J. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23670 · Cited by 230
Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
Schaffner, F., Ray, A., & Dontenwill, M. (2013) · Cancers · doi:10.3390/cancers5010027 · Cited by 234
Trends and Challenges in Tumor Anti-Angiogenic Therapies
Jászai, J., & Schmidt, M. H. H. (2019) · Cells · doi:10.3390/cells8091102 · Cited by 215
Angiopoietin–Tie signalling in the cardiovascular and lymphatic systems
Eklund, L., Kangas, J., & Saharinen, P. (2016) · Clinical Science · doi:10.1042/cs20160129 · Cited by 210
Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy
Gerald, D., Chintharlapalli, S. R., Augustin, H. G., & Benjamin, L. E. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4697 · Cited by 202
Self-citationKienast, Y., Klein, C., Scheuer, W., Raemsch, R., Lorenzon, E., Bernicke, D., Herting, F., Yu, S., The, H. H., Martarello, L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0081 · Cited by 201
Self-citationAngiogenic factors as potential drug target: Efficacy and limitations of anti-angiogenic therapy
Gacche, R. N., & Meshram, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.05.002 · Cited by 203
Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis
Ziegler, T., Horstkotte, J., Schwab, C., Pfetsch, V., Weinmann, K., Dietzel, S., Rohwedder, I., Hinkel, R., Groß, L., Lee, S.-M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66549 · Cited by 195
Self-citationFaricimab Treat-and-Extend for Diabetic Macular Edema
Wong, T. Y., Hašková, Z., Asik, K., Baumal, C. R., Csaky, K. G., Eter, N., Ives, J. A., Jaffe, G. J., Korobelnik, J., Lin, H., et al. (2023) · Ophthalmology · doi:10.1016/j.ophtha.2023.12.026 · Cited by 192
Orchestral actions of angiopoietin-1 in vascular regeneration
Koh, G. Y. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.010 · Cited by 183
Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma
Huang, R., & Rofstad, E. K. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0763-x · Cited by 183
Angiopoietin-2 Is Critical for Cytokine-Induced Vascular Leakage
Benest, A. V., Kruse, K., Savant, S., Thomas, M., Laib, A. M., Loos, E. K., Fiedler, U., & Augustin, H. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070459 · Cited by 178
Self-citationAngiopoietin-1 is required for Schlemm’s canal development in mice and humans
Thomson, B. R., Souma, T., Tompson, S. W. J., Onay, T., Kizhatil, K., Siggs, O. M., Feng, L., Whisenhunt, K. N., Yanovitch, T. L., Kalaydjieva, L. V., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95545 · Cited by 174
Savant, S., Porta, S. L., Budnik, A., Busch, K., Hu, J., Tisch, N., Korn, C., Valls, A. F., Benest, A. V., Terhardt, D., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.024 · Cited by 172
Self-citationReceptor Tyrosine Kinase-Mediated AngiogenesisPreprint
Jeltsch, M., Leppänen, V., Saharinen, P., & Alitalo, K. K. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009183 · Cited by 180
Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells
Duscher, D., Rennert, R. C., Januszyk, M., Anghel, E. L., Maan, Z. N., Whittam, A. J., Perez, M. G., Kosaraju, R. S., Hu, M. S.-M., Walmsley, G. G., et al. (2014) · Scientific Reports · doi:10.1038/srep07144 · Cited by 169
Intramyocardial haemorrhage after acute myocardial infarction
Betgem, R. P., de Waard, G. A., Nijveldt, R., Beek, A. M., Escaned, J., & van Royen, N. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.188 · Cited by 168
Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown
Ogura, S., Kurata, K., Hattori, Y., Takase, H., Ishiguro‐Oonuma, T., Hwang, Y., Ahn, S., Park, I., Ikeda, W., Kusuhara, S., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90905 · Cited by 173
Self-citationAngiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction
Lee, S.-J., Lee, C.-K., Kang, S., Park, I., Kim, Y. H., Kim, S. K., Hong, S. P., Bae, H., He, Y., Kubota, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99659 · Cited by 164
Nanomaterials and nanomaterials-based drug delivery to promote cutaneous wound healing
Liu, T., Lu, Y., Zhan, R., Qian, W., & Luo, G. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114670 · Cited by 164
Angiopoietin 2 Induces Pericyte Apoptosis via α3β1 Integrin Signaling in Diabetic Retinopathy
Park, S. W., Yun, J.-H., Kim, J. H., Kim, K.-W., Cho, C., & Kim, J. H. (2014) · Diabetes · doi:10.2337/db13-1942 · Cited by 157
Engineered delivery strategies for enhanced control of growth factor activities in wound healing
Niu, Y., Li, Q., Ding, Y., Dong, L., & Wang, C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.002 · Cited by 155
Angiogenesis in the ischemic core: A potential treatment target?
Kanazawa, M., Takahashi, T., Ishikawa, M., Onodera, O., Shimohata, T., & del Zoppo, G. J. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19834158 · Cited by 157
Santo, V. E., Gomes, M. E., Mano, J. F., & Reis, R. L. (2012) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2012.0138 · Cited by 157
Engineering therapeutic bispecific antibodies using CrossMab technology
Klein, C., Schäfer, W. M., Regula, J. T., Dumontet, C., Brinkmann, U., Bacac, M., & Umaña, P. (2018) · Methods · doi:10.1016/j.ymeth.2018.11.008 · Cited by 148
Self-citationSrivastava, K., Hu, J., Korn, C., Savant, S., Teichert, M., Kapel, S. S., Jugold, M., Besemfelder, E., Thomas, M., Pasparakis, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.11.005 · Cited by 140
Self-citationRedundant angiogenic signaling and tumor drug resistance
Gacche, R. N., & Assaraf, Y. G. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.01.002 · Cited by 140
Zhou, H. J., Qin, L., Zhang, H., Tang, W., Ji, W., He, Y., Liang, X., Wang, Z., Yuan, Q., Vortmeyer, A. O., et al. (2016) · Nature Medicine · doi:10.1038/nm.4169 · Cited by 140
Lee, J., Kim, K. E., Choi, D. K., Jang, J. Y., Jung, J.-J., Kiyonari, H., Shioi, G., Chang, W., Suda, T., Mochizuki, N., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006666 · Cited by 134
Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP
Souma, T., Thomson, B. R., Heinen, S., Carota, I. A., Yamaguchi, S., Onay, T., Liu, P., Ghosh, A. K., Li, C., Eremina, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714446115 · Cited by 138
Links between atherosclerotic and periodontal disease
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2016.01.006 · Cited by 132
CD40L and Its Receptors in Atherothrombosis—An Update
Michel, N. A., Zirlik, A., & Wolf, D. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00040 · Cited by 128
Angiopoietins and Tie2 in vascular inflammation
Parikh, S. M. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000361 · Cited by 122
Targeting tumor associated macrophages (TAMs) via nanocarriers
Singh, Y., Pawar, V. K., Meher, J. G., Raval, K., Kumar, A., Shrivastava, R., Bhadauria, S., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.395 · Cited by 122
A Linkage between Angiogenesis and Inflammation in Neovascular Age-Related Macular Degeneration
Heloterä, H., & Kaarniranta, K. (2022) · Cells · doi:10.3390/cells11213453 · Cited by 121
THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES
Heier, J. S., Singh, R. P., Wykoff, C. C., Csaky, K. G., Lai, T. Y. Y., Loewenstein, A., Schlottmann, P. G., Paris, L. P., Westenskow, P. D., & Quezada-Ruiz, C. (2020) · Retina · doi:10.1097/iae.0000000000003003 · Cited by 122
Leukocyte driven-decidual angiogenesis in early pregnancy
Lima, P. D. A., Zhang, J., Dunk, C., Lye, S. J., & Croy, B. A. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.63 · Cited by 116
Chen, L., Li, J., Wang, F., Dai, C., Wu, F., Liu, X., Li, T., Glauben, R., Zhang, Y., Nie, G., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1114 · Cited by 112
The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation
Milam, K. E., & Parikh, S. M. (2014) · Tissue Barriers · doi:10.4161/21688362.2014.957508 · Cited by 106
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
RANDI, A. M., Laffan, M., & Starke, R. D. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.060 · Cited by 105
Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice
Yang, H., Lee, S., Lee, S., Kim, K., Yang, Y., Kim, J. H., Adams, R. H., Wells, J. M., Morrison, S. J., Koh, G. Y., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64547 · Cited by 103
Dysregulation of the angiopoietin–Tie-2 axis in sepsis and ARDS
Parikh, S. M. (2013) · Virulence · doi:10.4161/viru.24906 · Cited by 103
Gene control of tyrosine kinase TIE2 and vascular manifestations of infections
Ghosh, C. C., David, S., Zhang, R., Berghelli, A. V., Milam, K. E., Higgins, S. J., Hunter, J. T., Mukherjee, A., Wei, Y., Tran, M. T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519467113 · Cited by 100
Porta, S. L., Roth, L., Singhal, M., Mogler, C., Spegg, C., Schieb, B., Qu, X., Adams, R. H., Baldwin, H. S., Savant, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94674 · Cited by 97
Self-citationShah, A. V., Birdsey, G. M., Peghaire, C. R., Pitulescu, M. E., Dufton, N., Yang, Y., Weinberg, I., Almagro, L. O., Payne, L., Mason, J. C., et al. (2017) · Nature Communications · doi:10.1038/ncomms16002 · Cited by 96
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy
D’Amico, G., Korhonen, E. A., Anisimov, A., Zarkada, G., Holopainen, T., Hägerling, R., Kiefer, F., Eklund, L., Sormunen, R. T., Elamaa, H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68897 · Cited by 97
Crist, A. M., Zhou, X., Garai, J., Lee, A. R., Thoele, J., Ullmer, C., Klein, C., Zabaleta, J., & Meadows, S. M. (2019) · Circulation · doi:10.1161/circulationaha.118.036952 · Cited by 98
Self-citationNanomaterials for Angiogenesis in Skin Tissue Engineering
Cui, L., Liang, J., Liu, H., Zhang, K., & Li, J. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0337 · Cited by 95
Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference
Biel, N. M., & Siemann, D. W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.035 · Cited by 95
Rahbarghazi, R., Nassiri, S. M., Ahmadi, S. H., Mohammadi, E., Rabbani, S., Araghi, A., & Hosseinkhani, H. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.008 · Cited by 89
Mending Leaky Blood Vessels: The Angiopoietin-Tie2 Pathway in Sepsis
David, S., Kümpers, P., Slyke, P. V., & Parikh, S. M. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201061 · Cited by 87
Angiopoietin 2 induces astrocyte apoptosis via αvβ5-integrin signaling in diabetic retinopathy
Yun, J.-H., Park, S. W., Kim, J. H., Park, Y., Cho, C.-H., & Kim, J. H. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.347 · Cited by 87
Role of VEGF-A and LRG1 in Abnormal Angiogenesis Associated With Diabetic Nephropathy
Zhang, A., Fang, H., Chen, J., He, L., & Chen, Y. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01064 · Cited by 84
NF1 Deletion Generates Multiple Subtypes of Soft-Tissue Sarcoma That Respond to MEK Inhibition
Dodd, R. D., Mito, J. K., Eward, W. C., Chitalia, R., Sachdeva, M., Ma, Y., Barretina, J., Dodd, L. G., & Kirsch, D. G. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0189 · Cited by 85
Cho, W. C., Jour, G., & Aung, P. P. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.015 · Cited by 83
Isidori, A. M., Venneri, M. A., & Fiore, D. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0502-0 · Cited by 83
Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
Hooglugt, A., van der Stoel, M. M., Boon, R. A., & Huveneers, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.612802 · Cited by 82
Forget, M. A., Voorhees, J. L., Cole, S. L., Dakhlallah, D. A., Patterson, I. L., Gross, A. C., Moldovan, L., Mo, X. M., Evans, R., Marsh, C. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098623 · Cited by 79
RetractedHove, I. V., Hu, T., Beets, K., Bergen, T. V., Etienne, I., Stitt, A. W., Vermassen, E., & Feyen, J. H. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100966 · Cited by 79
Hippo-YAP/TAZ signaling in angiogenesis
Park, J. A., & Kwon, Y. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.3.016 · Cited by 79
Ascending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels
Kenig-Kozlovsky, Y., Scott, R. P., Onay, T., Carota, I. A., Thomson, B. R., Gil, H. J., Ramirez, V., Yamaguchi, S., Tanna, C. E., Heinen, S., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017090962 · Cited by 78
Radke, J., Meinhardt, J., Aschman, T., Chua, R. L., Farztdinov, V. M., Lukassen, S., Ten, F. W., Friebel, E., Ishaque, N., Franz, J., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01573-y · Cited by 80
Fisher, J., Douglas, J. J., Linder, A., Boyd, J. H., Walley, K. R., & Russell, J. A. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001853 · Cited by 77
Angiopoietin-2 in white adipose tissue improves metabolic homeostasis through enhanced angiogenesis
An, Y., Sun, K., Joffin, N., Zhang, F., Deng, Y., Donzé, O., Kusminski, C. M., & Scherer, P. E. (2017) · eLife · doi:10.7554/elife.24071 · Cited by 77
Bochenek, M. L., Leidinger, C., Rosinus, N. S., Gogiraju, R., Guth, S., Hobohm, L., Jurk, K., Mayer, E., Münzel, T. F., Lankeit, M., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315259 · Cited by 76
ITGB3/CD61: a hub modulator and target in the tumor microenvironment.
Zhu, C., Kong, Z., Wang, B., Cheng, W., Wu, A., & Meng, X. (2019) · Europe PMC (PubMed Central) · Cited by 76
Hosseini, S. S., Khalili, S., Baradaran, B., Bidar, N., Shahbazi, M., Mosafer, J., Hashemzaei, M., Mokhtarzadeh, A., & Hamblin, M. R. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.058 · Cited by 76
Molecular Regulation of Sprouting Angiogenesis
Duran, C. L., Howell, D. W., Dave, J. M., Smith, R. L., Torrie, M. E., Essner, J. J., & Bayless, K. J. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160048 · Cited by 80
Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy
Deliyanti, D., Alrashdi, S. F., Tan, S. M., Meyer, C. J., Ward, K. W., de Haan, J. B., & Wilkinson‐Berka, J. L. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22920 · Cited by 75
Zhang, X., Yan, X., Wang, C., Tang, T., & Chai, Y. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.08.013 · Cited by 72
Angiogenic biomaterials to promote therapeutic regeneration and investigate disease progression
Ngo, M. T., & Harley, B. A. C. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120207 · Cited by 72
The Angiopoietin-Tie2 Pathway in Critical Illness
Sack, K. D., Kellum, J. A., & Parikh, S. M. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2019.12.003 · Cited by 70
Interactive phenotyping of large-scale histology imaging data with HistomicsML
Nalisnik, M., Amgad, M. T., Lee, S., Halani, S. H., Vega, J. E. V., Brat, D. J., Gutman, D. A., & Cooper, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-15092-3 · Cited by 67
Metadata
- Authors
- Felcht, M., Luck, R., Schering, A., Seidel, P., Srivastava, K., Hu, J., Bartol, A., Kienast, Y., Vettel, C., Loos, E. K., Kutschera, S., Bartels, S., Appak, S., Besemfelder, E., Terhardt, D., Chavakis, E., Wieland, T., Klein, C., Thomas, M., Uemura, A., Goerdt, S., & Augustin, H. G.
- Affiliations
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- Goethe University Frankfurt (DE)
- Corresponding author
- Augustin, Hellmut G.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-06-01
- Volume
- 122
- Issue
- 6
- Pages
- 1991-2005
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3366398
- OpenAlex
- W2157985193
- Cited by
- 479
- References
- 50
- Citations by year
- 2026: 20 · 2025: 33 · 2024: 28 · 2023: 44 · 2022: 29 · 2021: 21 · 2020: 31 · 2019: 36 · 2018: 37 · 2017: 40 · 2016: 40 · 2015: 37 · 2014: 41 · 2013: 30 · 2012: 12
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- Deutsche Forschungsgemeinschaft (Project B6, SFB873, SFB‐TR23)
- Aventis Foundation
- Japan Society for the Promotion of Science (22689046)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- angiopoietin-2, angiogenesis, Tie2, integrin signaling, FAK phosphorylation, Rac1 activation, sprouting angiogenesis, endothelial cells, tumor angiogenesis
- MeSH terms
- Animals, Female, Humans, Male, Melanoma, Neoplasm Proteins, Neovascularization, Pathologic, Neuropeptides, Phosphorylation, Signal Transduction, Down-Regulation, Integrins, rac GTP-Binding Proteins, Receptor Protein-Tyrosine Kinases, rac1 GTP-Binding Protein, Angiopoietin-2, Endothelial Cells, Receptor, TIE-2, Mice, Focal Adhesion Kinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
